Marché mondial de l’épanchement pleural – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché de l'épanchement pleural

Le marché mondial de l'épanchement pleural devrait connaître une croissance significative au cours de la période de prévision mentionnée. Les marchés en hausse et les investissements massifs dans la R&D sont les moteurs de la croissance de ce marché. La prévalence croissante des maladies pulmonaires dans le monde et les marchés émergents sont les facteurs responsables de la croissance de ce marché. Le COVID-19 a également eu un impact majeur sur la croissance du marché.

Data Bridge Market Research analyse le taux de croissance du marché mondial de l'épanchement pleural au cours de la période de prévision 2022-2029. Le TCAC attendu du marché mondial de l'épanchement pleural a tendance à être d'environ 6 % au cours de la période de prévision mentionnée. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe Data Bridge Market Research comprend également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Définition du marché

L'épanchement pleural est une accumulation de liquide dans les couches pleurales situées à l'extérieur des poumons. En général, une petite quantité de liquide est nécessaire au mouvement des poumons et à une respiration normale. La présence d'une affection spécifique telle qu'une cirrhose du foie, une embolie pulmonaire, une maladie rénale ou une pneumonie augmente le risque d'épanchement pleural. En outre, l'épanchement pleural peut provoquer un cancer du poumon chez les hommes et un cancer du sein chez les femmes. Il revêt une grande importance pour le secteur de la santé et devrait donc augmenter fortement au cours de la période de prévision.

Portée et segmentation du marché de l'épanchement pleural

Global Pleural Effusion Market Dynamics

Drivers

• Increase in Geriatric Population

The geriatric population is expected to increase the patient population globally, which boots the global hematuria treatment market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050, from 617 million in 2015. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increased Incidence of Pleural Effusion Disease

The incidence and prevalence of pleural effusions disease is growing fast globally. According to WHO, approximately one million pleural effusions cases are witnessed in the United States each year. Its incidence is increasing and its treatment is of great importance to the healthcare sector.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global pleural effusion market over a forecast period.

• High Cost

The huge expenditure of the treatment methods surely hamper the market growth.

This global pleural effusion market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pleural effusion market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pleural Effusion Market Scope

The global pleural effusion market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Transudative
• Exudative
• Others

Treatment

• Surgery
• Medication
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Pleural Effusion Market Regional Analysis/Insights

The global pleural effusion market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global pleural effusion market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to increasing infection in geriatric population, and growing population with cardiovascular diseases.

Asia-Pacific dominates the market due to increased prevalence of lung infections and associated diseases and increasing initiatives taken by the government and pharmaceutical organizations to spread awareness.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pleural Effusion Market Share Analysis

The global pleural effusion market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pleural effusion market.

Key players operating in the global pleural effusion market include:

• Pfizer Inc (U.S.)
• F. Hoffmann-La Roche SA (Suisse)
• Mylan NV (États-Unis)
• Fresenius Kabi AG (Allemagne)
• Hebei Changshan Biochemical Pharmaceutical Co. Ltd. (Chine)
• Hikma Pharmaceuticals PLC (Japon)
• Novartis AG (États-Unis)
• Shanghai Fosun Pharmaceutical (Group) Co., Ltd (Chine)
• Teva Pharmaceutical Industries Ltd. (Israël)
• HEYER Medical AG (Allemagne)
• Biometrix (Pays-Bas)
• Smiths Medical, Inc (États-Unis)

SKU-53635